Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KAT8 | Q9H7Z6 | 3/20 | 0.53 |
| ▸ | PPARA | Q07869 | 1/20 | 0.50 |
| ▸ | EP300 | Q09472 | 1/20 | 0.45 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.45 |
| ▸ | ESR1 | P03372 | 2/20 | 0.43 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.43 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.43 |
| ▸ | TACR2 | P21452 | 2/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.43 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | SHBG | P04278 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.43 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.43 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5015956 | 0.84 | PPARA (0.53) | PPARACYP3A4 | |
| SCHEMBL7157453 | 0.82 | KAT8 (0.45) | KAT8PPARAEP300KAT5ESR1 | |
| SCHEMBL5015897 | 0.82 | TRPV1 (0.47) | KAT8PPARAPTGS2TRPV1 | |
| SCHEMBL5016274 | 0.82 | TRPV1 (0.47) | KAT8PPARAPTGS2TRPV1 | |
| SCHEMBL5016692 | 0.82 | TRPV1 (0.47) | KAT8PPARAPTGS2TRPV1 | |
| SCHEMBL6559330 | 0.80 | KAT8 (0.54) | KAT8PPARAESR1ADRA2AADORA3 | |
| SCHEMBL27661495 | 0.80 | KAT8 (0.55) | KAT8PPARAEP300KAT5ALDH1A1 | |
| SCHEMBL14232569 | 0.79 | KAT8 (0.52) | KAT8PPARAESR1ADRA2AADORA3 | |
| SCHEMBL11727912 | 0.77 | KAT8 (0.75) | KAT8PPARAESR1ADRA2AADORA3 | |
| SCHEMBL27640988 | 0.77 | PPARA (0.44) | KAT8PPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7449608-B2 | Naphthol derivative and charge control agent comprising the same | UENO FINE CHEMICALS INDUSTRY, LTD. (JP) | 2008-11-11 | — | — | US | disclosed |
| US-20050119487-A1 | Naphthol derivative and charge control agent comprising the same | KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO (JP) | 2005-06-02 | — | — | US | disclosed |
| EP-1462440-A1 | NAPHTHOL DERIVATIVE AND CHARGE CONTROL AGENT COMPRISING THE SAME | Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo (JP) | 2004-09-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050119487-A1 | Naphthol derivative and charge control agent comprising the same | CECR2, PEF1, NAP1L1 | KAT8 782/4885PPARA 1369/4885EP300 377/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.